Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,820 | -5,500 | -3,640 | -1,040 | N/A |
| Depreciation Amortization | 40 | 80 | 80 | 110 | N/A |
| Other Working Capital | -910 | 1,430 | 690 | -40 | N/A |
| Other Operating Activity | 130 | 340 | 110 | -980 | 0 |
| Operating Cash Flow | $-2,560 | $-3,650 | $-2,760 | $-1,950 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | -3 | 330 | N/A |
| Other Investing Activity | -800 | -130 | 403 | 190 | 0 |
| Investing Cash Flow | $-800 | $-130 | $400 | $520 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 5,670 | 4,300 | 2,690 | 1,050 | 0 |
| Financing Cash Flow | $5,670 | $4,300 | $2,690 | $1,050 | $N/A |
| Exchange Rate Effect | 30 | -20 | 3 | 0 | N/A |
| Beginning Cash Position | 1,000 | 580 | 250 | 630 | N/A |
| End Cash Position | 3,340 | 1,070 | 590 | 250 | N/A |
| Net Cash Flow | $2,340 | $490 | $340 | $-380 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,560 | -3,650 | -2,760 | -1,950 | N/A |
| Free Cash Flow | -2,560 | -3,650 | -2,760 | -1,950 | 0 |